Dr Martens Plc Stock Performance
| DOCMF Stock | USD 1.03 0.02 1.98% |
On a scale of 0 to 100, Dr Martens holds a performance score of 8. The firm owns a Beta (Systematic Risk) of 0.61, which means possible diversification benefits within a given portfolio. As returns on the market increase, Dr Martens' returns are expected to increase less than the market. However, during the bear market, the loss of holding Dr Martens is expected to be smaller as well. Please check Dr Martens' sortino ratio, semi variance, and the relationship between the information ratio and value at risk , to make a quick decision on whether Dr Martens' current price history will revert.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Dr Martens plc are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak primary indicators, Dr Martens reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 117.2 M | |
| Total Cashflows From Investing Activities | -25 M |
DOCMF |
Dr Martens Relative Risk vs. Return Landscape
If you would invest 83.00 in Dr Martens plc on May 15, 2025 and sell it today you would earn a total of 20.00 from holding Dr Martens plc or generate 24.1% return on investment over 90 days. Dr Martens plc is currently producing 0.4256% returns and takes up 4.0997% volatility of returns over 90 trading days. Put another way, 36% of traded pink sheets are less volatile than DOCMF, and 92% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Dr Martens Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Dr Martens' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Dr Martens plc, and traders can use it to determine the average amount a Dr Martens' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1038
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | DOCMF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.1 actual daily | 36 64% of assets are more volatile |
Expected Return
| 0.43 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 8 92% of assets perform better |
Based on monthly moving average Dr Martens is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Dr Martens by adding it to a well-diversified portfolio.
Dr Martens Fundamentals Growth
DOCMF Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Dr Martens, and Dr Martens fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on DOCMF Pink Sheet performance.
| Return On Equity | 0.64 | |||
| Return On Asset | 0.16 | |||
| Profit Margin | 0.19 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 2.75 B | |||
| Shares Outstanding | 1 B | |||
| Price To Earning | 33.56 X | |||
| Price To Book | 5.71 X | |||
| Price To Sales | 2.43 X | |||
| Revenue | 908.3 M | |||
| EBITDA | 265 M | |||
| Cash And Equivalents | 228 M | |||
| Cash Per Share | 0.23 X | |||
| Total Debt | 280.9 M | |||
| Debt To Equity | 1.20 % | |||
| Book Value Per Share | 0.35 X | |||
| Cash Flow From Operations | 184.4 M | |||
| Earnings Per Share | 0.21 X | |||
| Total Asset | 859.1 M | |||
About Dr Martens Performance
By analyzing Dr Martens' fundamental ratios, stakeholders can gain valuable insights into Dr Martens' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Dr Martens has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Dr Martens has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Martens plc was founded in 1945 and is based in London, the United Kingdom. DR MARTENS operates under Footwear Accessories classification in the United States and is traded on OTC Exchange. It employs 2229 people.Things to note about Dr Martens plc performance evaluation
Checking the ongoing alerts about Dr Martens for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Dr Martens plc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Dr Martens plc has some characteristics of a very speculative penny stock | |
| Dr Martens plc had very high historical volatility over the last 90 days | |
| About 69.0% of the company shares are held by institutions such as insurance companies |
- Analyzing Dr Martens' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Dr Martens' stock is overvalued or undervalued compared to its peers.
- Examining Dr Martens' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Dr Martens' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Dr Martens' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Dr Martens' pink sheet. These opinions can provide insight into Dr Martens' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for DOCMF Pink Sheet analysis
When running Dr Martens' price analysis, check to measure Dr Martens' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Martens is operating at the current time. Most of Dr Martens' value examination focuses on studying past and present price action to predict the probability of Dr Martens' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Martens' price. Additionally, you may evaluate how the addition of Dr Martens to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |